Alternate Health Invited to Present at the American Medical Marijuana Physicians Association's Annual Conference

TORONTO, Oct. 5, 2017 /CNW/ - Alternate Health Corp ("Alternate Health" or the "Company") (CSE:AHG) (OTC:AHGIF), an international medical cannabis company that uses best-in-class technology, research, education, production and laboratories to increase the awareness, regulatory compliance, and appropriate usage of cannabinoids in modern medical practices, today announced that the company will present at the upcoming AMMPA Annual Conference just outside Orlando, Florida.

"Following the AMMPA's historic endorsement of Alternate Health's CanaPass Patient Management System, we are proud to announce the launch of FlorPass at the AMMPA Annual Conference," says Dr. Michael Murphy, CEO of Alternate Health. "FlorPass is the latest version of the CanaPass system, adapted to the legal and regulatory environment of medical cannabis in the state of Florida."

Alternate Health's Chief Legal Officer, George Mull, will be presenting on the importance of transparency and regulatory compliance in prescribing medical cannabis. With an expected audience of hundreds of physicians, George Mull will demonstrate how FlorPass is a unique and powerful tool to combine the spheres of strong clinical oversight and strict legal compliance.

FlorPass's key feature is the way it connects patients, physicians and cannabis producers in one system, supporting transparent records of all prescriptions, transactions and medical data. Alternate Health's recent addition of the Blockchain Ledger to the system gives FlorPass an unrivalled level of transparency and regulatory oversight across the industry.

"Our system offers physicians, patients and government officials the oversight and data they need to adapt to Florida's new medical cannabis regulations," says Dr. Murphy. "FlorPass is the perfect tool for Florida's medical cannabis community,"

AMMPA Annual Conferences attendees will have the chance to demo the software and see how FlorPass can assist doctors in improving medical cannabis patient outcomes at their practices. Representatives from Alternate Health will be available to answer questions about FlorPass and network with potential new users of the system.

The three-day conference is held annually by the AMMPA, offering doctors and medical professionals the opportunity to update and expand their knowledge regarding sophisticated diagnostic and practice guidelines, to share new ideas for evaluation and treatment techniques, and to increase the practitioner's knowledge and ability to act and advocate for patients within the current medical legislative and regulatory environment. Educational formats include lectures, PowerPoint presentations, panel discussions and Q&A sessions.

About Alternate Health Corp.

Alternate Health Corp. (CSE: AHG, OTCQB: AHGIF) is an international medical cannabis company that uses best in class technology, research, education, production and laboratories to increase the awareness, regulatory compliance, and appropriate usage of cannabinoids in modern medical practices.  The company is strategically positioned in all facets of the medical cannabis value chain through the innovative integration of proprietary technology and know-how, acquisitions and partnerships, deep direct knowledge of and experience with improving patient outcomes, and management expertise. 

Alternate Health is well positioned to reinvest internal operating cash flow in its platform over the long term, creating an attractive investment profile for its shareholders.

Alternate Health resides in the cannabis sector along with companies like GW Pharmaceuticals (OTCMKTS:GWPRF), AXIM Biotechnologies Inc. (OTCMKTS:AXIM), Canopy Growth Corporation (TSE:WEED), and Aphria Inc. (TSE:APH). The difference with Alternate Health is their focus is on servicing regulatory providers as opposed to marketing a commodity.

For more information about Alternate Health Corp., visit www.alternatehealth.ca

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as "forward-looking statements". Forward-looking statements may be identified by words including "anticipates", "believes", "intends", "estimates", "expects" and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company's future operations, business prospects and financing plans, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements.

SOURCE Alternate Health Corp.